CN114432001A - stent graft - Google Patents
stent graft Download PDFInfo
- Publication number
- CN114432001A CN114432001A CN202210255550.2A CN202210255550A CN114432001A CN 114432001 A CN114432001 A CN 114432001A CN 202210255550 A CN202210255550 A CN 202210255550A CN 114432001 A CN114432001 A CN 114432001A
- Authority
- CN
- China
- Prior art keywords
- stent
- proximal
- main body
- segment
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000007789 sealing Methods 0.000 claims abstract description 89
- 230000007704 transition Effects 0.000 claims abstract description 56
- 210000000746 body region Anatomy 0.000 claims abstract description 21
- 230000003014 reinforcing effect Effects 0.000 claims description 42
- 239000012528 membrane Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 7
- 238000004873 anchoring Methods 0.000 claims description 6
- 230000004323 axial length Effects 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims 3
- 230000018109 developmental process Effects 0.000 claims 1
- 206010063659 Aversion Diseases 0.000 abstract 1
- 210000002489 tectorial membrane Anatomy 0.000 abstract 1
- 239000010408 film Substances 0.000 description 29
- 210000004204 blood vessel Anatomy 0.000 description 26
- 238000000034 method Methods 0.000 description 13
- 208000001750 Endoleak Diseases 0.000 description 11
- 210000000702 aorta abdominal Anatomy 0.000 description 11
- 238000010586 diagram Methods 0.000 description 11
- 206010064396 Stent-graft endoleak Diseases 0.000 description 10
- 238000006073 displacement reaction Methods 0.000 description 10
- 210000003090 iliac artery Anatomy 0.000 description 10
- 230000003902 lesion Effects 0.000 description 8
- 238000004904 shortening Methods 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 101100222276 Drosophila melanogaster cuff gene Proteins 0.000 description 4
- 241000628997 Flos Species 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000007769 metal material Substances 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000002788 crimping Methods 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229910000619 316 stainless steel Inorganic materials 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 2
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 2
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 206010002895 aortic dissection Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000013039 cover film Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
本申请是申请号为202111487656.7的分案申请。This application is a divisional application with application number 202111487656.7.
技术领域technical field
本发明属于医疗器械技术领域,特别涉及一种覆膜支架。The invention belongs to the technical field of medical devices, and particularly relates to a covered stent.
背景技术Background technique
血管介入治疗作为一种微创伤的治疗方式,为不能耐受外科手术的血管疾病患者提升了生存概率。人体血管分叉点众多,一些动脉瘤或夹层的病变区域会累及到血管分叉点及其分支。以腹主动脉为例,腹主动脉远端分叉成为两侧髂动脉。针对腹主动脉动脉瘤或夹层病例,常规的血管介入治疗手术,会在病变区域采用主体支架(置于腹主动脉病变处)和分支支架(置于双侧髂动脉病变处)在体内拼接的方式重建血流通道,尤其是病变累及到髂动脉处时,这种治疗方法更为有效。其中主体支架多数采用倒钩设计,倒钩刺破血管以进行锚定,但是这种治疗方法需要3个独立成型的支架,增加了手术成本,而且支架间的拼接也增加了拼接处内漏的风险,同时也延长了手术时间,对患者不利。目前也有极少量的一体式支架产品,但这些产品整体采用编织结构,压握尺寸大,柔顺性差,而且内漏风险高,也存在着远期移位等缺点。Vascular interventional therapy, as a minimally invasive treatment, improves the survival probability for patients with vascular disease who cannot tolerate surgery. There are many vascular bifurcation points in the human body, and some lesions of aneurysm or dissection will involve the vascular bifurcation points and their branches. Taking the abdominal aorta as an example, the distal end of the abdominal aorta bifurcates into the iliac arteries on both sides. For cases of abdominal aortic aneurysm or dissection, conventional vascular interventional surgery will use the main stent (placed at the abdominal aorta lesion) and the branch stent (placed at the bilateral iliac artery lesion) in the lesion area to splicing in vivo. This method is more effective when the iliac artery is involved in the reconstruction of blood flow. Most of the main stents are designed with barbs, and the barbs puncture the blood vessels for anchoring. However, this treatment method requires 3 independently formed stents, which increases the operation cost, and the splicing between the stents also increases the risk of endoleak at the splicing. Risk, but also prolong the operation time, which is not good for the patient. At present, there are also a very small number of integrated stent products, but these products adopt a braided structure as a whole, with large crimping size, poor flexibility, high risk of endoleak, and long-term displacement.
因此有必要提供一种新型的覆膜支架,以克服现有治疗病变区域累及到血管分叉点及分支的支架所存在的问题。Therefore, it is necessary to provide a new type of stent-graft to overcome the problems of existing stents for treating diseased areas involving vascular bifurcations and branches.
发明内容SUMMARY OF THE INVENTION
为了解决现有技术中所存在的技术问题,本发明的目的在于提供一种覆膜支架,能够改善带有分支的覆膜支架的柔顺性,还能够减小覆膜支架的压握尺寸,同时降低了内漏以及远期移位的风险。In order to solve the technical problems existing in the prior art, the purpose of the present invention is to provide a stent-graft, which can improve the flexibility of the stent-graft with branches, and can also reduce the size of the pressure-grip of the stent-graft, and at the same time The risk of endoleak and long-term displacement is reduced.
为实现上述目的及其它相关目的,本发明提供了一种覆膜支架,包括支架本体和覆膜,所述覆膜设置在所述支架本体的表面,所述支架本体包括主体支架部和分支支架部,两个所述分支支架部和一个所述主体支架部均与所述覆膜固定连接并形成Y形结构,所述支架本体包括若干轴向依次间隔排布的环形支架段;In order to achieve the above object and other related objects, the present invention provides a stent-graft, including a stent body and a membrane, the membrane is arranged on the surface of the stent body, and the stent body includes a main body support part and a branch support two of the branch support parts and one of the main body support parts are fixedly connected with the covering film and form a Y-shaped structure, and the support body includes a plurality of annular support segments arranged at intervals in the axial direction;
所述主体支架部包括从近端至远端依次排布的近端密封区、主体区和过渡区;所述主体区具有相同的外径;所述过渡区的外径由近端向远端依次减小;所述过渡区的近端的外径与所述主体区的外径相同;The main body support part includes a proximal sealing area, a main body area and a transition area arranged in sequence from the proximal end to the distal end; the main body area has the same outer diameter; the outer diameter of the transition area is from the proximal end to the distal end decrease in sequence; the outer diameter of the proximal end of the transition zone is the same as the outer diameter of the main body zone;
所述支架段包括近端密封支架段、过渡支架段、主体支架段和分支支架段;所述近端密封区包括所述近端密封支架段,所述过渡区包括所述过渡支架段,所述主体区包括所述主体支架段;The stent segment includes a proximal sealing stent segment, a transition stent segment, a main body stent segment and a branch stent segment; the proximal sealing region includes the proximal sealing stent segment, the transition region includes the transition stent segment, and the the body region includes the body support segment;
所述近端密封支架段的波杆的最大长度小于所述主体支架段的波杆的长度。The maximum length of the stem of the proximal seal stent segment is less than the length of the stem of the body stent segment.
可选的,所述覆膜支架还包括加强筋,与所述覆膜固定连接,所述加强筋沿所述主体支架部的轴向延伸设置;所述加强筋的近端设置于所述主体区上,所述加强筋的远端设置于所述过渡区的近端,所述加强筋能够限制所述主体支架部在轴向上的回缩。Optionally, the covered stent further includes a reinforcing rib, which is fixedly connected with the covering film, the reinforcing rib is arranged along the axial extension of the main body support part; the proximal end of the reinforcing rib is arranged on the main body In the area, the distal end of the reinforcing rib is disposed at the proximal end of the transition area, and the reinforcing rib can limit the axial retraction of the main body support portion.
可选的,所述加强筋的长度为所述主体区的轴向长度的1%~80%。Optionally, the length of the reinforcing rib is 1% to 80% of the axial length of the main body region.
可选的,所述加强筋的远端设置于所述过渡区的近端的第一个所述过渡支架段的波峰上,和/或,所述加强筋的近端设置于所述主体区的近端的第一个所述主体支架段上。Optionally, the distal end of the reinforcing rib is arranged on the wave crest of the first transition bracket segment at the proximal end of the transition area, and/or the proximal end of the reinforcing rib is arranged in the main body area. The proximal end of the first of the body stent segments.
可选的,所述近端密封区包括至少一个变高近端密封支架段和至少一个等高近端密封支架段;所述至少一个变高近端密封支架段和所述至少一个等高近端密封支架段在所述主体支架部的轴向上间隔排列,且在所述主体支架部的周向上对齐布置;所述至少一个变高近端密封支架段设置在所述近端密封区的最近端;所述至少一个变高近端密封支架段中的任意相邻两个矮波谷间设置至少一个高波谷。Optionally, the proximal sealing area includes at least one heightened proximal sealing stent segment and at least one equal-height proximal sealing stent segment; the at least one heightened proximal sealing stent segment and the at least one equal-height proximal sealing stent segment. The end seal bracket segments are arranged at intervals in the axial direction of the main body bracket portion, and are aligned in the circumferential direction of the main body bracket portion; the at least one raised proximal end seal bracket segment is provided on the proximal end seal region. The most proximal end; at least one high wave trough is arranged between any two adjacent low wave troughs in the at least one heightened proximal end sealing stent segment.
可选的,所述主体支架部还包括裸段,所述裸段包括一个环形支架段,所述裸段的远端与所述覆膜固定连接,所述裸段的近端轴向上伸出所述覆膜,所述裸段被配置为扩张后与血管壁贴合进行锚定,所述裸段上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。Optionally, the main body support part further includes a bare segment, the bare segment includes an annular support segment, the distal end of the bare segment is fixedly connected to the covering film, and the proximal end of the bare segment extends axially upward. After the membrane is pulled out, the bare segment is configured to adhere to the vessel wall for anchoring after expansion, and a post-release structure is provided on the bare segment for cooperating with the delivery device to realize post-release of the stent-graft.
可选的,所述裸段上设置有凹槽结构,所述凹槽结构内设置有显影部件。Optionally, a groove structure is provided on the bare segment, and a developing component is provided in the groove structure.
可选的,所述凹槽结构包括第一凹槽结构和第二凹槽结构,所述第一凹槽结构的长度大于所述第二凹槽结构的长度,所述第一凹槽结构和所述第二凹槽结构设置在所述裸段的不同的波杆上,所述第一凹槽结构的下边缘与所述第二凹槽结构的下边缘平齐,以使所述显影部件的下边缘与所述覆膜的近端边缘重合。Optionally, the groove structure includes a first groove structure and a second groove structure, the length of the first groove structure is greater than the length of the second groove structure, the first groove structure and The second groove structure is arranged on different wave rods of the bare segment, and the lower edge of the first groove structure is flush with the lower edge of the second groove structure, so that the developing component The lower edge of the membrane coincides with the proximal edge of the membrane.
可选的,所述第一凹槽结构的长度为所述第二凹槽结构的长度的1.5倍~3倍。Optionally, the length of the first groove structure is 1.5 times to 3 times the length of the second groove structure.
可选的,所述近端密封区包括一个变高近端密封支架段和至少一个等高近端密封支架段,所述一个变高近端密封支架段和最近端的所述一个等高近端密封支架段在所述主体支架部的轴向上重叠排列,且在所述主体支架部的周向上错开布置;所述至少一个变高近端密封支架段设置在所述近端密封区的最近端;所述至少一个变高近端密封支架段中的任意相邻两个矮波峰间设置至少一个高波峰。Optionally, the proximal sealing area includes a heightened proximal sealing stent segment and at least one equal-height proximal sealing stent segment, and the one heightened proximal sealing stent segment and the proximal-most equal-height proximal end. The sealing bracket segments are arranged in an overlapping manner in the axial direction of the main body bracket portion, and are arranged staggered in the circumferential direction of the main body bracket portion; the at least one heightened proximal sealing bracket segment is arranged at the nearest end of the proximal sealing region. At least one high wave crest is arranged between any two adjacent short wave crests in the at least one heightened proximal sealing stent segment.
可选的,最近端的所述一个变高近端密封支架段的高波峰的近端轴向上伸出所述覆膜形成伸出段,所述伸出段被配置为扩张后与血管壁贴合进行锚定,所述伸出段上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。Optionally, the proximal end of the high crest of the most proximal-higher proximal-end sealing stent segment extends axially from the membrane to form a protruding segment, and the protruding segment is configured to adhere to the blood vessel wall after expansion. The protruding section is provided with a post-release structure for cooperating with the delivery device to realize post-release of the stent-graft.
可选的,所述伸出段的长度为1.5mm~5.0mm。Optionally, the length of the protruding section is 1.5mm˜5.0mm.
可选的,所述主体区的横截面形状为圆形,所述过渡区的近端的横截面形状为圆形,所述过渡区的远端的横截面形状为椭圆形。Optionally, the cross-sectional shape of the main body area is circular, the cross-sectional shape of the proximal end of the transition area is circular, and the cross-sectional shape of the distal end of the transition area is elliptical.
可选的,所述覆膜支架还包括分支束缚线圈,被配置为用于绑扎同侧的分支支架部的每个支架段,同侧的分支支架部的每个支架段由至少两个所述分支束缚线圈进行绑扎。Optionally, the stent-graft further includes a branch binding coil configured to bind each stent segment of the branch stent part on the same side, and each stent segment of the branch stent part on the same side is composed of at least two said stents. Branch tying coils for tying.
在上述覆膜支架中,利用覆膜将环形支架段进行连接而形成一体式的Y形覆膜支架,这种覆膜支架大大降低了手术成本,减少了传统术式支架间的拼接所拥有的内漏的风险,同时也降低了手术时间。此外,该一体式覆膜支架在释放后主体支架部的远端“骑跨”在血管分叉点上,这种固定方式符合人体血管的自然走向,支架分叉点不会发生移位。另外,环形支架段具有更小的压握尺寸,更小的导入路径,而且环形支架段之间通过覆膜柔性连接,相比于编织结构,增加了支架的柔顺性,能更好的与人体迂曲的血管进行匹配。再者,所述主体支架部还包括过渡区,所述过渡区的外径从近端至远端逐渐减小,使其可以与覆膜贴合的更好,也更符合人体血管直径自然变化趋势,进一步减小内漏的风险。再次,所述主体支架部还包括近端密封区,所述近端密封区包括至少一个变高近端密封支架段,所述至少一个变高近端密封支架段可使支架拥有更好的近端圆整性和更大的径向支撑力,可有效地预防由支架近端与血管贴合不严造成的I型内漏,同时近端第一段变高的结构设计也可配合后释放使支架释放精准,进一步提升释放精度。In the above-mentioned stent-grafts, the annular stent segments are connected by a membrane to form an integrated Y-shaped stent-graft, which greatly reduces the operation cost and reduces the cost of splicing between traditional surgical stents. The risk of endoleak is also reduced while the operation time is reduced. In addition, the distal end of the stent graft of the main body "rides" on the bifurcation point of the blood vessel after the release, this fixing method conforms to the natural trend of human blood vessels, and the bifurcation point of the stent will not shift. In addition, the annular stent segments have a smaller crimping size and a smaller introduction path, and the annular stent segments are flexibly connected by a membrane, which increases the flexibility of the stent compared to the braided structure and can better connect with the human body. Tortuous vessels are matched. Furthermore, the main body stent part also includes a transition area, and the outer diameter of the transition area gradually decreases from the proximal end to the distal end, so that it can fit better with the covering film, and is more in line with the natural changes in the diameter of human blood vessels. trend to further reduce the risk of endoleak. Thirdly, the main body stent portion further includes a proximal sealing area, the proximal sealing area includes at least one heightened proximal sealing stent segment, and the at least one heightened proximal sealing stent segment enables the stent to have a better proximal end. End roundness and greater radial support force can effectively prevent type I endoleak caused by poor adhesion between the proximal end of the stent and the blood vessel. At the same time, the structural design of the first section of the proximal end to become higher can also be released after cooperation. Make the bracket release more precise and further improve the release accuracy.
在上述覆膜支架中,利用加强筋限制主体支架部在轴向上的回缩,在不影响支架柔顺性的情况下,有效的降低了支架近端移位的风险,使释放位置更加精准。In the above-mentioned stent-graft, reinforcing ribs are used to limit the retraction of the main body stent portion in the axial direction, which effectively reduces the risk of proximal displacement of the stent and makes the release position more accurate without affecting the flexibility of the stent.
在上述覆膜支架中,所述主体支架部还包括裸段或伸出段,裸段或伸出段上优选设置后释放结构,可与输送器匹配以实现后释放的功能。后释放可有效的减少支架释放过程中的前跳与后跳,使释放位置更加准确。同时配合“骑跨式定位”和加强筋的设置,定位效果更好,而且裸段或伸出段无需倒钩,可以既在近端锚定支架,又不损伤血管。In the above-mentioned stent-graft, the main body stent part further includes a bare segment or a protruding segment, and the bare segment or the protruding segment is preferably provided with a post-release structure, which can be matched with the conveyor to realize the post-release function. The rear release can effectively reduce the forward and backward jumps during the bracket release process, making the release position more accurate. At the same time, with the "straddle-type positioning" and the setting of reinforcing ribs, the positioning effect is better, and no barbs are required for the bare or protruding sections, which can anchor the stent at the proximal end without damaging the blood vessel.
在上述覆膜支架中,可利用分支束缚线圈如蝴蝶型线圈,对同侧的分支支架部进行绑扎,可有效避免释放时线结点被卡主导致的支架无法弹开的问题,降低了手术难度,进一步缩短了手术时间In the above-mentioned stent-grafts, branch binding coils such as butterfly coils can be used to bind the branch stent parts on the same side, which can effectively avoid the problem that the stent cannot be opened due to the wire node being stuck during release, and reduces the operation time. Difficulty, further shortening the operation time
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to these drawings without creative efforts.
图1是本发明优选实施例一的覆膜支架的结构示意图。FIG. 1 is a schematic structural diagram of a stent graft according to a preferred embodiment 1 of the present invention.
图2是本发明优选实施例一的裸段的局部结构示意图。FIG. 2 is a partial structural schematic diagram of the bare segment of the preferred embodiment 1 of the present invention.
图3是本发明优选实施例一的加强筋的结构示意图。FIG. 3 is a schematic structural diagram of a reinforcing rib according to a preferred embodiment 1 of the present invention.
图4是本发明优选实施例一的牙线绑扎主体支架部的结构示意图。FIG. 4 is a schematic structural diagram of the bracket portion of the main body of the dental floss binding according to the first preferred embodiment of the present invention.
图5是本发明优选实施例一的分支束缚线圈绑扎同侧的分支支架部的结构示意图。5 is a schematic structural diagram of a branch support portion on the same side of the branch binding coil binding in the preferred embodiment 1 of the present invention.
图6是本发明优选实施例二的覆膜支架的结构示意图。FIG. 6 is a schematic structural diagram of the stent graft according to the second preferred embodiment of the present invention.
图7a是本发明优选实施例二的变高近端密封支架段的结构示意图。Fig. 7a is a schematic structural diagram of the heightened proximal sealing stent segment according to the second preferred embodiment of the present invention.
图7b是本发明优选实施例二的等高近端密封支架段的结构示意图。Fig. 7b is a schematic structural diagram of a proximal sealing stent segment of equal height according to the second preferred embodiment of the present invention.
图7c是本发明优选实施例二的等高近端密封支架段和变高近端密封支架段在轴向上重叠且在周向上交错布置的示意图。Fig. 7c is a schematic diagram of the same-height proximal sealing stent segment and the heightened proximal sealing stent segment overlapping in the axial direction and staggered in the circumferential direction according to the second preferred embodiment of the present invention.
具体实施方式Detailed ways
为使本发明的内容更加清楚易懂,以下结合说明书附图本发明做进一步说明。当然本发明并不局限于该具体实施例,本领域的技术人员所熟知的一般替换也涵盖在本发明的保护范围内。在不冲突的情况下,下述的实施方式及实施方式中的特征可以相互补充或相互组合。In order to make the content of the present invention clearer and easier to understand, the present invention will be further described below with reference to the accompanying drawings. Of course, the present invention is not limited to this specific embodiment, and general substitutions known to those skilled in the art are also covered within the protection scope of the present invention. The following embodiments and features in the embodiments may complement each other or be combined with each other without conflict.
在本申请使用的术语是仅仅出于描述特定实施方式的目的,而非旨在限制本申请。在本申请中所使用的单数形式的“一种”、“所述”和“该”也旨在包括多数形式,除非上下文清楚地表示其他含义。应当理解,“一个”或者“一”等类似词语也不表示数量限制,而是表示存在至少一个;“多个”表示两个及两个以上的数量。“包括”或者“包含”等类似词语意指出现在“包括”或者“包含”前面的元件或者物件涵盖出现在“包括”或者“包含”后面列举的元件或者物件及其等同,并不排除其他元件或者物件。其次,本发明利用示意图进行了详细的表述,但这些示意图仅为了便于详述本发明实例,不应对此作为本发明的限定。如在本文中“近端”是指靠近心脏的一端;“远端”是指靠近操作者的一端,也即远离心脏的一端;“轴向”是指平行于轴线的方向;“径向”是指垂直于轴线的方向;“周向”是指围绕轴线的方向。如在本文中“波杆”即为支架棱,“波杆的长度”是指支架棱在其延伸方向上的尺寸。The terms used in this application are for the purpose of describing particular embodiments only and are not intended to limit the application. As used in this application, the singular forms "a," "the," and "the" are intended to include the plural forms as well, unless the context clearly dictates otherwise. It should be understood that words like "a" or "an" do not denote a quantitative limitation, but rather denote that there is at least one; "a plurality" denotes a quantity of two or more. Words like "include" or "include" mean that the elements or items appearing before "including" or "including" cover the elements or items listed after "including" or "including" and their equivalents, and do not exclude other elements or objects. Next, the present invention is described in detail by using schematic diagrams, but these schematic diagrams are only for the convenience of describing the examples of the present invention in detail, and should not be regarded as a limitation of the present invention. As used herein, "proximal" refers to the end close to the heart; "distal" refers to the end close to the operator, that is, the end away from the heart; "axial" refers to the direction parallel to the axis; "radial" refers to the direction perpendicular to the axis; "circumferential" refers to the direction around the axis. As used herein, the "wave rod" refers to the stent rib, and the "wave rod length" refers to the dimension of the stent rib in the extending direction thereof.
<实施例一><Example 1>
如图1所示,本实施例提供一种覆膜支架100,为一体式支架结构,也即,该覆膜支架100并非由多个独立的支架在体内拼接而成,而是在体外便制作形成一个带有分支的支架结构。该覆膜支架100适用于动脉瘤或夹层的病变区域累及血管分叉点及其分支的情况,包括但不限于腹主动脉。以下描述中,主要以病变区域累及腹主动脉及其分支作为示意进行说明,但不构成对本发明的限定。As shown in FIG. 1 , the present embodiment provides a stent-
具体地,所述覆膜支架100包括支架本体,所述支架本体包括主体支架部110和两个分支支架部120,所述覆膜支架100还包括覆膜130。两个分支支架部120和一个主体支架部110都与覆膜130固定连接,从而一体连接成Y形的覆膜支架100。所需理解,支架本体与覆膜可以是一体式结构,也可以是分体式结构,无论是分体还是一体都可以实现支架本体与覆膜之间的固定连接。本文中,两个分支支架部120分别构成同侧的分支支架和对侧的分支支架,且为了便于解释说明,两个分支支架部120定义为第一分支支架部121和第二分支支架部122,第一分支支架部121构成同侧的分支支架,第二分支支架部122构成对侧的分支支架。分支支架部120的外径可以是近端小、远端大,或者分支支架部120的外径不变。Specifically, the stent-
主体支架部110和分支支架部120都为中空的管状结构,主体支架部110的内腔与两个分支支架部120的内腔连通。主体支架部110和分支支架部120都包括若干轴向依次间隔排布的环形支架段(简称支架段),环形支架段为波浪形结构,且环形支架段之间通过覆膜130柔性连接,或者支架段之间除加强筋105外仅通过覆膜130柔性连接。此处“柔性连接”可以理解为环形支架段都仅与覆膜130固定连接,而在轴向方向上任意相邻两个环形支架段之间没有刚性连接件进行连接。如图1所示,在优选情况下,环形支架段之间除加强筋105外无刚性连接,也即,环形支架段之间仅通过覆膜130连接,而覆膜130较为柔软可实现柔性连接。所应理解,“刚性连接”是指当覆膜支架产生位移或受力时,覆膜支架中的环形支架段之间不产生相对位移或变形;“柔性连接”是指覆膜支架产生位移或受力时,覆膜支架中的环形支架段之间可产生相对位移或变形,此时,柔顺性好。Both the main
本申请对环形支架段上的波形形状不作限制,可以是锯齿形或弧形或其他合适形状。本申请对制作支架本体的金属材料不作特别的限制,只要是生物相容性好的医用金属材料即可,如316不锈钢、钴铬合金或镍钛合金等医用金属材料。覆膜130为生物相容性好的高分子软性材料,可使支架本体在轴向上形成封闭的内腔,覆膜130可以设置在支架本体的内表面或外表面。The present application does not limit the shape of the waveform on the annular support segment, which can be a zigzag shape or an arc shape or other suitable shapes. The application does not specifically limit the metal material for making the stent body, as long as it is a medical metal material with good biocompatibility, such as 316 stainless steel, cobalt-chromium alloy or nickel-titanium alloy and other medical metal materials. The
与现有技术相比,本发明的覆膜支架100不但避免了多个独立支架在体内进行拼接所引起的内漏风险,而且缩短了手术时间,极大降低了手术成本。尤其主体支架部110的远端以“骑跨”的方式定位在腹主动脉血管分叉点上,这种固定方式符合人体血管的自然走向,覆膜支架100的分叉点不会发生移位,可有效的降低覆膜支架移位的风险。此外,该覆膜支架100与整体编织的支架结构不同,波浪形的环形支架段具有更小的压握尺寸,这意味着更小的导入路径,对患者的损伤小。而且波浪形的环形支架段之间无刚性连接或除加强筋外无刚性连接,相比于整体编织结构,增加了支架的柔顺性,能更好的与人体迂曲的血管进行匹配,治疗效果更好。Compared with the prior art, the stent-
继续参考图1,主体支架部110优选包括从近端至远端依次排布的裸段101、近端密封区102和主体区103,都与覆膜130固定连接,如与覆膜130缝合和/热熔固定连接。具体地,所述环形支架段包括裸段101、近端密封支架段a2和主体支架段a3;所述裸段101也可以理解为包括一个环形支架段;所述近端密封区102包括若干近端密封支架段a2,具体数量不作限定;所述主体区103包括若干主体支架段a3,具体数量亦不限定。应理解,裸段101上不覆盖覆膜130,近端密封区102和主体区103上都设置有覆膜130。还需理解,所述环形支架段还包括分支支架段,且每个所述分支支架部包括分支支架段。Continuing to refer to FIG. 1 , the main
如图2所示,可通过切割工艺制成裸段101,该裸段101即为一个波浪形的环形支架段,裸段101的远端与覆膜130固定连接,裸段101的近端轴向上伸出覆膜130。裸段101被配置为扩张后与血管壁贴合进行锚定,从而可以延长主体支架部110近端的锚定区,而且裸段101无倒钩,可以既在近端锚定支架,又不损伤血管。优选的,裸段101上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。后释放可有效的减少支架释放过程中的前跳与后跳,使释放位置更加精确,治疗效果更好。本申请对后释放的方式不加限制。在一实施例中,如图2所示,所述后释放结构包括孔洞结构1011,裸段101的至少部分波峰上设置孔洞结构1011,该孔洞结构1011用于与输送器匹配,以实现覆膜支架的后释放。As shown in FIG. 2 , a
优选的,裸段101上设置有显影部件(未图示),所述显影部件由金属显影材料制成,以便根据显影部件在X射线下的显影性辨别覆膜支架100的位置和形态。进一步的,裸段101的波杆1012上设置有凹槽结构,所述凹槽结构用于固定显影部件。所述凹槽结构可包括若干第一凹槽结构1013和若干第二凹槽结构1014,第一凹槽结构1013可以固定第一显影部件,第二凹槽结构1014可以固定第二显影部件。第一凹槽结构1013和第二凹槽结构1014设置在裸段101的波杆1012的表面上,且第一凹槽结构1013和第二凹槽结构1014设置在裸段101的不同的波杆1012上。优选的,裸段101的波杆1012的表面凸起,从而在凸起之间形成凹槽结构,从而保证裸段101的强度。所述第一凹槽结构1013的长度大于第二凹槽结构1014的长度,因此,第一显影部件的长度大于第二显影部件的长度。应理解,所述凹槽结构的长度即为沿波杆1012的延伸方向的尺寸。优选的,第一凹槽结构1013的下边缘与第二凹槽结构1014的下边缘平齐,确保显影部件的下边缘与覆膜130的边缘重合,更方便识别覆膜支架近端的位置及形态。所述凹槽结构的下边缘指的是凹槽结构的远端边缘。可选的,第二凹槽结构1014的长度可为1mm~3mm,第一凹槽结构1013的长度可为2mm~6mm。进一步的,第一凹槽结构1013的长度为第二凹槽结构1014的长度的1.5倍~3倍,保证支架覆膜近端的位置及形态可在X射线下被识别。本实施例中,在支架的对侧设置了第一凹槽结构1013来固定第一显影部件,其他方位根据需求设置了第二凹槽结构1014来固定第二显影部件,以用于在X射线下识别支架方向及形态。Preferably, a developing member (not shown) is provided on the
请参考图1,近端密封区102包括至少一个变高近端密封支架段1021和至少一个等高近端密封支架段1022。变高近端密封支架段1021中的波谷的深度不相同,且至少一个变高近端密封支架段1021中的任意相邻两个矮波谷之间设置至少一个高波谷。等高近端密封支架段1022中的波谷的深度都相同。“波谷的深度”是指相邻波峰到波谷之间的垂直距离。至少一个变高近端密封支架段1021设置在近端密封区102的最近端。近端密封区102中的等高密封支架段1022的数量不限定,可以是一个或多个。同理,变高近端密封支架段1021的数量可以是一个或多个。至少一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在主体支架部110的轴向上间隔排列,且在主体支架部110的周向上对齐布置。Referring to FIG. 1 , the
在图1示出的实施例中,变高近端密封支架段1021的数量为1个,等高近端密封支架段1022的数量为3个,一个变高近端密封支架段1021和三个等高密封支架段1022依次由近端至远端沿主体支架部110的轴向间隔排布,且变高近端密封支架段1021和等高密封支架段1022在主体支架部110的周向上对齐布置。此处,“对齐”是指,如图1所示,在平行于主体支架部的轴线的投影平面上,变高近端密封支架段1021的波峰的投影与等高密封支架段1022的波峰的投影的连线平行于主体支架部的轴线,同样的,变高近端密封支架段1021的波谷的投影与等高密封支架段1022的波谷的投影的连线平行于主体支架部的轴线。应理解,采用变高和等高两种高度的支架段的组合设置,可使覆膜支架100的近端与血管贴合更加紧密,从而有效防止由覆膜支架100的近端与血管贴合不紧所产生的Ia型内漏。In the embodiment shown in FIG. 1 , the number of heightened proximal sealing
此外,近端密封支架段a2的波杆的最大长度小于主体支架段a3中的波杆长度,例如近端密封支架段a2的波杆长度为4mm~14mm,主体支架段a3中的波杆长度为16mm~24mm。因此,近端密封区102相比于主体区103的波形更为密集,与血管的贴合效果更好。In addition, the maximum length of the wave rod of the proximal sealing stent segment a2 is smaller than that of the main body stent segment a3. For example, the wave rod length of the proximal sealing stent segment a2 is 4 mm to 14 mm, and the wave rod length of the main body stent 16mm to 24mm. Therefore, the waveform of the
继续参考图1,主体区103包括若干轴向依次排布的主体支架段a3,主体支架段a3的数量根据病变区域的长度进行设置。组成主体区103的主体支架段a3的波峰的高度相同。主体区103的作用是支撑血流通道,使覆膜支架100贴壁。近端密封区102和主体区103都大体为圆柱形状,两者的外径相同。Continuing to refer to FIG. 1 , the
主体支架部110优选还包括过渡区104,所述裸段101、近端密封区102、主体区103和过渡区104从近端至远端依次排布,从而在主体区103和分支支架部120之间设置有过渡区104。过渡区104的外径从近端至远端依次减小,所述过渡区104的近端的外径与主体区103的外径相同,所述主体区103具有相同的外径。此外,所述环形支架段还包括过渡支架段a4,所述过渡区104包括若干过渡支架段a4。优选的,主体区103的横截面形状为圆形;优选的,过渡区104的近端的横截面形状为圆形,过渡区104的远端的横截面形状为椭圆形,椭圆形的长轴和短轴都依次减小。组成过渡区104的过渡支架段a4的数量不做限制,包括但不限于一个过渡支架段a4,通常为一个过渡支架段a4即可。因此,在优选情况下,主体支架部110的近端横截面为圆形,远端横截面为椭圆形。过渡区104的作用在于使主体支架部110与两个分支支架部120过渡平滑,以符合人体血管解剖构造,贴合效果好。此外,过渡区104采用了变径结构,能够与覆膜130的变径段贴合的更好,也更符合人体血管直径自然变化趋势。故相比于传统的等径结构,过渡区104的设置,可以使覆膜支架具有更好的内腔保持性,有效避免了支架的分支随着血管迂曲而产生闭塞的问题。The main
所述覆膜支架100优选还包括加强筋105,与覆膜130固定连接,所述加强筋105被配置用于限制主体支架部110在轴向上的回缩。使用加强筋105后,在尽可能保留覆膜支架100的柔顺性能的基础上,可有效防止覆膜支架100轴向短缩,有效降低覆膜支架100的近端移位的风险。优选的,所述加强筋105的材料为生物形容性好的金属材料,包括且不限于镍钛、钴铬合金或316不锈钢。The stent-
请参考图3,并结合图1,加强筋105为细长的杆状结构并沿主体支架部110的轴向延伸设置,且加强筋105的近端和远端均与覆膜130固定连接,如缝合和/或热熔连接。其中加强筋105的近端设置在主体区103上,远端设置在过渡区104的近端,以限制主体区103的轴向缩短。此处,应理解,加强筋105实际与覆膜130固定连接,但加强筋105与覆膜130的固定位置需要确保加强筋105的远端在过渡区104的近端,加强筋105的近端在主体区103上。优选的,加强筋105的近端设置于主体区103的近端的第一个主体支架段a3上,如固定在主体区103的近端的第一个主体支架段a3的波峰、波谷或波峰与波谷之间的位置。Please refer to FIG. 3 , in conjunction with FIG. 1 , the reinforcing
加强筋105的数量优选为一根,以确保覆膜支架的柔顺性。优选的,加强筋105的远端设置于过渡区104的近端的第一个过渡支架段a4上,更优选,加强筋105的远端设置在过渡区104的近端的第一个过渡支架段a4的波峰上。本申请对加强筋105的长度不作特别的限定,具体根据主体支架部110的规格来确定加强筋105的长度。例如在一具体的实施例中,加强筋105的长度为主体区103的轴向长度的1%~80%。The number of reinforcing
进一步的,如图3所示,加强筋105的两端可设置固定孔1051,所述加强筋105通过两端的固定孔1051与覆膜130缝合连接和/或热熔连接。固定孔1051的设置,可保证加强筋105的两端与覆膜130固定牢靠,不易滑脱。覆膜支架100的定位方式为支架分叉点“骑跨”在腹主动脉分叉点,配合加强筋105,可有效防止覆膜支架在迂曲的腹主动脉中发生短缩,确保定位的精确性。还应理解,本文中,环形支架段朝向近端凸起的为“波峰”,反之为“波谷”。Further, as shown in FIG. 3 , both ends of the reinforcing
返回参考图1,所述覆膜支架100优选还包括牙线140,由PTFE、PET或超高分子聚乙烯等具有良好生物相容性的软性高分子材料制成。牙线140的近端与覆膜130固定连接,并用于绑扎主体支架部110的每个环形支架段,以减小支架的尺寸,便于在体内进行支架的位置调整。Referring back to FIG. 1 , the stent-
请参考图1,将牙线140进行打结,在打结处形成若干主体束缚线圈141。主体束缚线圈141的数量和位置与需要绑扎的主体支架部110上的环形支架段的数量和位置一一对应。绑扎时,如图4所示,优选主体束缚线圈141穿过支架段上对应位置的束缚线圈106,可将主体支架部110的直径束缚最小,约为支架名义直径的10%~20%。其中束缚线圈106起到对主体束缚线圈141限位的作用,绑扎更为可靠和牢固。束缚线圈106的数量和位置可根据需求进行设置。这种绑扎结构可靠且强度高。束缚线圈106的结构不作限定,可以是在支架上额外缝合形成束缚线圈106。Referring to FIG. 1 , the
参考图1,所述覆膜支架100还可包括分支束缚线圈150,由PTFE、PET或超高分子聚乙烯等具有良好生物相容性的软性高分子材料制成。可选的,所述分支束缚线圈150为蝴蝶型线圈,即“8”字形线圈。其中,第一分支支架部121的每个环形支架段上设置至少2个分支束缚线圈150,且每个环形支架段的至少2个分支束缚线圈150优选固定在该支架段的同一圆周方向上,至少2个分支束缚线圈150分别从两侧环抱支架段。由于采用翻山的手术方式,使得对侧的第二分支支架部122无需绑扎分支束缚线圈150。此处的“翻山”的手术方式为本领域的公知技术,即可以理解为,腹主动脉与双侧髂动脉为倒Y字型结构,翻山即为从一侧髂动脉采用导丝导管等耗材建立双侧髂动脉的通路,形似翻山。Referring to FIG. 1 , the stent-
请参考图5,分支束缚线圈150采用两侧环绕对第一分支支架部121进行绑扎的方式,即2个从同一点出发的分支束缚线圈150从两侧将第一分支支架部121“抱住”,以达到绑扎束缚的效果。该结构简单,易操作,绑扎效果牢靠。采用这种绑扎结构,拉动束缚导丝,即可实现第一分支支架部121的释放,可有效避免释放时线结点被卡住导致的支架无法弹开。同样地,分支束缚线圈150可以配合第一分支支架部121的支架段上的束缚线圈106(图5未示出)使用,束缚线圈106起到对分支束缚线圈150限位的作用,绑扎更可靠。Please refer to FIG. 5 , the
人的血管尺寸及分布特征个体差异性较大,为此,覆膜支架100的尺寸可按照患者的血管尺寸进行选择。在一示意性实施例中,如图1所示,主体支架部110的长度L1为30mm~130mm,主体支架部110的直径D1为16mm~34mm,第一分支支架部121的长度L2为20mm~80mm,第二分支支架部122的长度L3为20mm~80mm,第一分支支架部121的直径D2为8mm~24mm,第二分支支架部122的直径D3为8mm~24mm。与传统覆膜支架不同的是,当患者髂动脉病变处血管直径很大时,仍然可根据患者的特殊情况调整分支支架部120的大小,最终做成一体式覆膜支架100。即两分支支架部120的直径之和可大于主体支架部110的直径,当然也可小于或等于主体支架部110的直径。The size and distribution characteristics of human blood vessels vary greatly among individuals. Therefore, the size of the
<实施例二><Example 2>
请参考图6、图7a、图7b和图7c,在本发明的另一个实施例中,还提供了一种覆膜支架100’,该覆膜支架100’取消了裸段,而在主体支架部110的近端直接配置近端密封区102’,也即,本实施例的覆膜支架100’的主体支架部110包括从近端至远端依次排布的近端密封区102’、主体区103和过渡区104。另外的不同是,该近端密封区102’中的变高近端密封支架段121和等高近端密封支架段122的相对位置有所调整。Please refer to FIG. 6 , FIG. 7 a , FIG. 7 b and FIG. 7 c , in another embodiment of the present invention, a stent-
具体地,在本实施例中,近端密封区102’包括一个变高近端密封支架段1021和至少一个等高近端密封支架段1022。将一个变高近端密封支架段1021和最近端的一个等高近端密封支架段1022在主体支架部110的轴向上重叠排列,且在主体支架部110的周向上错开布置,从而在近端密封区102的最近端形成一个变高和等高交叠设置的支架段。交叠后形成的环形支架段中任意相邻两个矮波峰之间设置至少一个高波峰。其中高波峰的下顶点与矮波峰的下顶点对齐并在同一圆周上。因此,交叠后形成的环形支架段的下顶点对齐,上顶点呈现高矮变化。还应理解,所述“轴向上重叠”指的是,一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在同一圆周方向上;“周向上错开布置”指的是,一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在同一圆周方向上的波峰之间错开而不重叠,具体见图7c。该方案中,至少一个变高近端密封支架段1021设置在近端密封区102’的最近端,至少一个变高近端密封支架段1021中的任意相邻两个矮波峰间设置至少一个高波峰。Specifically, in the present embodiment, the proximal sealing region 102' includes one proximal sealing
此时,主体支架部110在最近端的变高和等高的交错式结构设计,可使支架近端与血管紧密贴合,可有效防止由支架近端与血管贴合不紧所产生的Ia型内漏,同时也可使支架拥有更好的近端圆整性和更大的径向支撑力,从而可有效地预防由支架近端与血管贴合不严造成的I型内漏,同时近端首段变高的结构设计也可配合后释放使支架释放精准。At this time, the staggered structure design of the height and the same height at the proximal end of the main
如图6所示,最近端的一个变高近端密封支架段1021的高波峰的近端轴向上伸出覆膜130的部分形成伸出段,此时,伸出段的长度优选为1.5mm~5mm,变高近端密封支架段1021中的高波峰的数量约为3-6个,而且高波峰上可设置孔洞结构来配合输送器实现后释放的功能,可有效的减少支架释放过程中的前跳与后跳,使释放位置更加准确。而且这种结构方便与圆筒状支架(CUFF)配合使用。与普通CUFF配合使用可增加治疗区域的长度。与各种开孔CUFF配合使用时,开孔CUFF可重建近端内脏区分支血管的血流通道。使用方式及尺寸十分灵活。As shown in FIG. 6 , the protruding section is formed by the proximal end of the high crest of the proximal-most heightened proximal sealing
本实施例所示出的覆膜支架100’的其余结构与实施例一中的覆膜支架100的结构基本相同,对于相同部分,不再详细描述,具体可参阅上述实施例一。The rest of the structure of the stent graft 100' shown in this embodiment is basically the same as the structure of the
应理解,本发明的覆膜支架在释放后,覆膜支架的分叉点与人体髂动脉分叉点重合,即支架主体支架部的远端骑跨在髂动脉分叉点上。这种固定方式符合人体血管的自然走向,支架分叉点不会发生移位,尤其配合加强筋时,加强筋远端设置于过渡区近端,有效降低支架短缩和近端移位的风险。同时裸段或伸出段的无倒钩设计一方面避免了倒钩对血管的损伤,另一方面延长了支架近端的锚定区,从而可以拓宽支架的使用范围,也使支架近端可以很好地与血管锚定。此外,近端密封区和过渡区的特殊结构设计可以使主体支架部与血管紧密贴合,极大地降低了Ia型内漏的风险。由于人体腹主动脉远端分叉成为两侧髂动脉,故,本发明的覆膜支架特别适合于腹主动脉,同时本申请的内漏风险和远期移位风险低,有效的弥补了现有覆膜支架所存在的缺点。It should be understood that after the stent-graft of the present invention is released, the bifurcation point of the stent-graft coincides with the bifurcation point of the human iliac artery, that is, the distal end of the stent part of the stent body rides on the bifurcation point of the iliac artery. This fixation method conforms to the natural trend of human blood vessels, and the stent bifurcation point will not be displaced. Especially when the reinforcing ribs are used, the distal end of the reinforcing ribs is set at the proximal end of the transition area, which effectively reduces the risk of stent shortening and proximal displacement. . At the same time, the barb-free design of the bare segment or the extended segment avoids the damage of the barb to the blood vessel on the one hand, and on the other hand extends the anchoring area of the proximal end of the stent, thereby broadening the scope of use of the stent, and also enabling the proximal end of the stent to Well anchored to blood vessels. In addition, the special structural design of the proximal sealing area and the transition area can make the main body stent fit closely with the blood vessel, which greatly reduces the risk of type Ia endoleak. Since the distal end of the human abdominal aorta bifurcates into the iliac arteries on both sides, the stent-graft of the present invention is particularly suitable for the abdominal aorta, and at the same time, the risk of endoleak and long-term displacement of the present application is low, effectively making up for the existing There are disadvantages of stent grafts.
上述描述仅是对本发明较佳实施例的描述,并非对本发明范围的任何限定,本发明领域的普通技术人员根据上述揭示内容做的任何变更、修饰,均属于本发明的保护范围。The above description is only a description of the preferred embodiments of the present invention, and is not intended to limit the scope of the present invention. Any changes and modifications made by those of ordinary skill in the field of the present invention based on the above disclosure all belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210255550.2A CN114432001A (en) | 2021-12-08 | 2021-12-08 | stent graft |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111487656.7A CN113876467B (en) | 2021-12-08 | 2021-12-08 | stent graft |
CN202210255550.2A CN114432001A (en) | 2021-12-08 | 2021-12-08 | stent graft |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111487656.7A Division CN113876467B (en) | 2021-12-08 | 2021-12-08 | stent graft |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114432001A true CN114432001A (en) | 2022-05-06 |
Family
ID=79015909
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111487656.7A Active CN113876467B (en) | 2021-12-08 | 2021-12-08 | stent graft |
CN202210255550.2A Withdrawn CN114432001A (en) | 2021-12-08 | 2021-12-08 | stent graft |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111487656.7A Active CN113876467B (en) | 2021-12-08 | 2021-12-08 | stent graft |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN113876467B (en) |
WO (1) | WO2023104001A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023104001A1 (en) * | 2021-12-08 | 2023-06-15 | 上海微创心脉医疗科技(集团)股份有限公司 | Covered stent |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116965990A (en) * | 2022-04-22 | 2023-10-31 | 上海蓝脉医疗科技有限公司 | Medical support |
CN114652495B (en) * | 2022-05-18 | 2022-08-30 | 上海微创心脉医疗科技(集团)股份有限公司 | Covered stent |
CN115381610B (en) * | 2022-10-27 | 2023-01-31 | 北京华脉泰科医疗器械股份有限公司 | High compliance tectorial membrane support |
CN117100456B (en) * | 2023-10-18 | 2024-02-02 | 北京华脉泰科医疗器械股份有限公司 | Vascular stent and conveyor thereof |
CN117918998A (en) * | 2023-12-05 | 2024-04-26 | 杭州创心医学科技有限公司 | A coated stent |
CN117442405B (en) * | 2023-12-25 | 2024-03-22 | 北京华脉泰科医疗器械股份有限公司 | Integrated aortic multi-branch stent and aortic vascular repair assembly |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6942691B1 (en) * | 2000-04-27 | 2005-09-13 | Timothy A. M. Chuter | Modular bifurcated graft for endovascular aneurysm repair |
CN101176686A (en) * | 2007-11-20 | 2008-05-14 | 微创医疗器械(上海)有限公司 | Tectorial bracket |
US20110218617A1 (en) * | 2010-03-02 | 2011-09-08 | Endologix, Inc. | Endoluminal vascular prosthesis |
CN102247231A (en) * | 2011-03-31 | 2011-11-23 | 微创医疗器械(上海)有限公司 | Improved intraoperation stent system |
US20120150273A1 (en) * | 2009-07-31 | 2012-06-14 | Jotec Gmbh | One-piece bifurcation graft |
US20140058402A1 (en) * | 2012-08-27 | 2014-02-27 | Cook Medical Technologies Llc | Endoluminal prosthesis and delivery device |
CN104586537A (en) * | 2013-10-31 | 2015-05-06 | 微创心脉医疗科技(上海)有限公司 | Covered stent |
CN106344209A (en) * | 2016-10-11 | 2017-01-25 | 有研医疗器械(北京)有限公司 | Abdominal aorta covered stent and conveying device thereof and using method |
CN107569311A (en) * | 2017-07-05 | 2018-01-12 | 杭州唯强医疗科技有限公司 | Ring holder |
CN208229020U (en) * | 2017-08-01 | 2018-12-14 | 有研医疗器械(北京)有限公司 | A kind of branch type film-coated vascular bracket |
CN212415985U (en) * | 2020-06-30 | 2021-01-29 | 上海微创心脉医疗科技股份有限公司 | Stent system |
WO2021219074A1 (en) * | 2020-04-30 | 2021-11-04 | 杭州唯强医疗科技有限公司 | Covered stent |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2817768Y (en) * | 2005-05-24 | 2006-09-20 | 微创医疗器械(上海)有限公司 | Tectorium stand and host cage section thereof |
CN2845771Y (en) * | 2005-11-03 | 2006-12-13 | 微创医疗器械(上海)有限公司 | Artificial blood vessel rack capable of preventing internal leaking |
CN101836911A (en) * | 2009-03-18 | 2010-09-22 | 微创医疗器械(上海)有限公司 | Collateral filmed stent |
US20130289701A1 (en) * | 2012-04-27 | 2013-10-31 | Medtronic Vascular, Inc. | Stent-graft prosthesis for placement in the abdominal aorta |
AU2013206712B1 (en) * | 2013-07-03 | 2013-11-28 | Cook Medical Technologies Llc | Endovascular graft having a cannulation pocket |
CN105848611B (en) * | 2013-12-24 | 2019-01-29 | 尼普洛株式会社 | bracket |
CN104706448B (en) * | 2015-03-26 | 2017-03-08 | 黄连军 | Overlay film frame and overlay film frame induction system |
CN105030373A (en) * | 2015-09-07 | 2015-11-11 | 湖南埃普特医疗器械有限公司 | Aorta covered stent |
CN205041568U (en) * | 2015-09-30 | 2016-02-24 | 韩新巍 | Sealed mounting system of main common iliac artery tumour intracavity of type of falling Y integration |
CN105213074B (en) * | 2015-10-21 | 2017-04-05 | 湖南埃普特医疗器械有限公司 | A kind of overlay film frame and its using method |
CA3055567C (en) * | 2017-03-08 | 2021-11-23 | W. L. Gore & Associates, Inc. | Steering wire attach for angulation |
CN107397610A (en) * | 2017-08-25 | 2017-11-28 | 杭州唯强医疗科技有限公司 | Overlay film frame |
JP2022500134A (en) * | 2018-09-12 | 2022-01-04 | エンドーロジックス リミテッド ライアビリティ カンパニー | Stent graft system and method with inflatable filling structure and fillable cuff |
CN109350310B (en) * | 2018-12-14 | 2021-07-02 | 宁波健世科技股份有限公司 | Valve stent capable of avoiding coronary artery blockage |
CN111067664B (en) * | 2019-12-25 | 2022-07-05 | 先健科技(深圳)有限公司 | Covered stent |
CN111437087B (en) * | 2020-04-02 | 2024-03-19 | 杭州唯强医疗科技有限公司 | bifurcated stent |
CN112603594B (en) * | 2020-12-25 | 2024-08-20 | 卢莉茵 | Vascular stent graft, vascular stent graft component and vascular stent graft binding method |
CN112773585B (en) * | 2020-12-30 | 2023-11-14 | 杭州唯强医疗科技有限公司 | Implantation of stents |
CN113876467B (en) * | 2021-12-08 | 2022-04-15 | 上海微创心脉医疗科技(集团)股份有限公司 | stent graft |
-
2021
- 2021-12-08 CN CN202111487656.7A patent/CN113876467B/en active Active
- 2021-12-08 CN CN202210255550.2A patent/CN114432001A/en not_active Withdrawn
-
2022
- 2022-12-06 WO PCT/CN2022/136747 patent/WO2023104001A1/en active Application Filing
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6942691B1 (en) * | 2000-04-27 | 2005-09-13 | Timothy A. M. Chuter | Modular bifurcated graft for endovascular aneurysm repair |
CN101176686A (en) * | 2007-11-20 | 2008-05-14 | 微创医疗器械(上海)有限公司 | Tectorial bracket |
US20120150273A1 (en) * | 2009-07-31 | 2012-06-14 | Jotec Gmbh | One-piece bifurcation graft |
US20110218617A1 (en) * | 2010-03-02 | 2011-09-08 | Endologix, Inc. | Endoluminal vascular prosthesis |
CN102247231A (en) * | 2011-03-31 | 2011-11-23 | 微创医疗器械(上海)有限公司 | Improved intraoperation stent system |
US20140058402A1 (en) * | 2012-08-27 | 2014-02-27 | Cook Medical Technologies Llc | Endoluminal prosthesis and delivery device |
CN104586537A (en) * | 2013-10-31 | 2015-05-06 | 微创心脉医疗科技(上海)有限公司 | Covered stent |
CN106344209A (en) * | 2016-10-11 | 2017-01-25 | 有研医疗器械(北京)有限公司 | Abdominal aorta covered stent and conveying device thereof and using method |
CN107569311A (en) * | 2017-07-05 | 2018-01-12 | 杭州唯强医疗科技有限公司 | Ring holder |
CN208229020U (en) * | 2017-08-01 | 2018-12-14 | 有研医疗器械(北京)有限公司 | A kind of branch type film-coated vascular bracket |
WO2021219074A1 (en) * | 2020-04-30 | 2021-11-04 | 杭州唯强医疗科技有限公司 | Covered stent |
CN212415985U (en) * | 2020-06-30 | 2021-01-29 | 上海微创心脉医疗科技股份有限公司 | Stent system |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023104001A1 (en) * | 2021-12-08 | 2023-06-15 | 上海微创心脉医疗科技(集团)股份有限公司 | Covered stent |
Also Published As
Publication number | Publication date |
---|---|
CN113876467B (en) | 2022-04-15 |
CN113876467A (en) | 2022-01-04 |
WO2023104001A1 (en) | 2023-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113876467B (en) | stent graft | |
JP6781203B2 (en) | Intraluminal prosthesis with diversionable bifurcation | |
EP0951253B1 (en) | Apparatus for delivering and deploying an endoprosthesis | |
JP6784490B2 (en) | Macrovascular stent graft for debranching and how to use | |
JP6071244B2 (en) | Stent and stent graft | |
JP2013543416A (en) | Stent graft system | |
CN118490412A (en) | Vascular stent, stent system and delivery system | |
WO2024198794A1 (en) | Fenestrated stent, covered stent system, and suturing method for fenestrated stent | |
CN112842619A (en) | Bow covered stent and covered stent conveyor | |
WO2023221712A1 (en) | Covered stent | |
CN114681113A (en) | Covered stent system | |
CN113081388A (en) | Covered stent system and covered stent thereof | |
CN204364174U (en) | The collateral type intravascular stent of iliac artery | |
CN216136110U (en) | Covered stent system | |
WO2014045428A1 (en) | Indwelling device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220506 |